Hi all this is the best that my son could do hopefully it helps and is understood by all
Attached is the flow chart however the arrows didn't copy across the text has been reformatted orrespond with the attached flow chart
1. Re-introduction into Australia (approvals in place)
• Release in South East Asia
• Regulatory program Europe
• Regulatory program USA
2. a) New refined formulations
• Non-regulated
• Cosmetic
• Post Surgical
2. b) Out-License Fractions
• Biological Activity
• Fraction Indication
• Major pharmaceutical companies are currently reviewing the scientific portfolio
SUMMARY OF
CORPORATE OBJECTIVES
• To utilize existing approvals in Australia and Asia to generate revenues
• To utilize existing approvals and registrations to enable the clinical programs necessary for early entry into the European and US markets
• To utilize existing approvals to expand into new Rx indications
• To develop a range of OTC and professional cosmetic and non-therapeutic products
• To out-licence the fractionation and isolation opportunities for unique patentable entities
- Forums
- ASX - By Stock
- CAI
- i know when the share will spike
i know when the share will spike, page-9
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAI (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAI (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online